推薦低氧性呼吸衰竭患者使用高流量臂套管(High flow nasal cannula,,HFNC)氧療,而不是傳統(tǒng)的氧療(conventional oxygen therapy,,COT)(強(qiáng)烈推薦,中度確定證據(jù))對(duì)于插管時(shí)間超過24小時(shí)且具有任何高危特征的患者,,與COT相比我們推薦采用HFNC(有條件推薦,中度確定證據(jù))對(duì)于臨床醫(yī)生常規(guī)拔管后使用無創(chuàng)正壓通氣(Non-invasive positive pressure ventilation,,NIPPV)的患者,,建議繼續(xù)使用NIPPV而不是HFNC(有條件的推薦,低確定性的證據(jù))關(guān)于插管期間使用HFNC,,我們無推薦意見。對(duì)于已經(jīng)接受HFNC的患者,,建議在插管期間繼續(xù)HFNC(有條件的推薦,,中等的確定性)對(duì)于接受心臟或胸腔手術(shù)的高危和/或肥胖患者,,與COT相比我們建議使用HFNC,,以預(yù)防術(shù)后即刻呼吸衰竭(有條件的推薦,中等的確定性證據(jù))反對(duì)預(yù)防性HFNC用于預(yù)防其他術(shù)后患者的呼吸衰竭(有條件的推薦,,非常低的確定性證據(jù))Intensive Care Med. 2020 Dec;46(12):2226-2237. doi: 10.1007/s00134-020-06312-y. Epub 2020 Nov 17.The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline
|